29 June 2017 | Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.
| Webster, L; Groskreutz, D; Grinbergs-Saull, A; et al. |
1 May 2017 | Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.
| Webster, L; Groskreutz, D; Grinbergs-Saull, A; et al. |
9 October 2017 | Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies?
| Watson, R; Colloby, SJ; Blamire, AM; et al. |
27 March 2021 | Hippocampal and Insula volume in mild cognitive impairment with Lewy bodies
| Firbank, MJ; Durcan, R; O'Brien, JT; et al. |
28 July 2021 | Improving the diagnosis and management of Lewy body dementia: the DIAMOND-Lewy research programme including pilot cluster RCT
| O'Brien, JT; Taylor, J-P; Thomas, A; et al. |
22 September 2020 | Introduction of a management toolkit for Lewy body dementia: A pilot cluster randomised trial
| O'Brien, JT; McKeith, IG; Thomas, AJ; et al. |
21 October 2020 | Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling
| Firbank, MJ; O'Brien, JT; Durcan, R; et al. |
25 August 2020 | Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile
| Donaghy, PC; Ciafone, J; Durcan, R; et al. |
17 November 2020 | Mild Cognitive Impairment: the Manchester Consensus
| Dunne, RA; Aarsland, D; O'Brien, JT; et al. |
23 September 2021 | Slowing on quantitative EEG is associated with transition to dementia in mild cognitive impairment
| Hamilton, CA; Schumacher, J; Matthews, F; et al. |
27 March 2021 | Utility of the pareidolia test in mild cognitive impairment with Lewy bodies and Alzheimer’s disease
| Hamilton, CA; Matthews, FE; Allan, LM; et al. |